Cargando…
Interferon-β 1a and SARS Coronavirus Replication
A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort...
Autores principales: | Hensley, Lisa E., Fritz, Elizabeth A., Jahrling, Peter B., Karp, Christopher, Huggins, John W., Geisbert, Thomas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322919/ https://www.ncbi.nlm.nih.gov/pubmed/15030704 http://dx.doi.org/10.3201/eid1002.030482 |
Ejemplares similares
-
The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)
por: Zaucha, Gary M, et al.
Publicado: (2001) -
Lack of Effect of Lamivudine on Ebola Virus Replication
por: Hensley, Lisa E., et al.
Publicado: (2015) -
Inhibition of Monkeypox virus replication by RNA interference
por: Alkhalil, Abdulnaser, et al.
Publicado: (2009) -
Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines
por: Morgenstern, Birgit, et al.
Publicado: (2005) -
Development of a New Vaccine for the Prevention of Lassa Fever
por: Geisbert, Thomas W, et al.
Publicado: (2005)